Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05745389 · ClinicalTrials.gov registry record
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
A clinical trial of Alopecia Areata, sponsored by CorEvitas.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05745389 is a study of Alopecia Areata that is actively recruiting participants, run by CorEvitas. The registered enrollment target is 5,000 participants, above the 1,763-participant average among 26 other Alopecia Areata trials with a reported enrollment target (184% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05745389, a study of Alopecia Areata, is actively recruiting participants, sponsored by CorEvitas.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Conditions Studied
Study Locations (1)
Massachusetts
- CorEvitas, LLC - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-10-25 |
| Est. Completion | 2099-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05745389
The ClinicalTrials.gov registry entry for NCT05745389 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,763-participant average among 26 other Alopecia Areata trials with a reported enrollment target (184% higher). The listed sponsor is CorEvitas, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alopecia Areata appearing as the primary indexed condition, and to 0 interventions.
NCT05745389 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05745389 about?
NCT05745389 is a clinical study titled "CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry". Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
What is the current status of trial NCT05745389?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2022-10-25. Estimated completion is 2099-12-31.
What conditions does trial NCT05745389 study?
This clinical trial studies the following conditions: Alopecia Areata.
Who is sponsoring clinical trial NCT05745389?
This trial is sponsored by CorEvitas, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05745389 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alopecia Areata
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
RECRUITING · Phase 2
-
A Study of LAD603 in Adults With Alopecia Areata
RECRUITING · Phase 2
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
RECRUITING · Phase 1
-
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
RECRUITING
-
Dupilumab in the Treatment of Pediatric Alopecia Areata
RECRUITING · Phase 2
-
Intralesional Cyclosporine for Alopecia Areata
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.